Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2
- PMID: 17875679
- DOI: 10.1158/0008-5472.CAN-07-1684
Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2
Abstract
Recent findings indicate that tumor-associated macrophages are important drivers of tumor angiogenesis. Here, we review the essential role played by Tie2-expressing monocytes (TEM) in this phenomenon. TEMs are present in human blood and tumors and their elimination in various tumor models suppresses tumor angiogenesis. A ligand for Tie2, angiopoietin-2 (Ang-2), is produced by angiogenic tumor vessels and is a chemoattractant for TEMs. Hypoxia up-regulates Tie2 expression on TEMs and, together with Ang-2, down-regulates their antitumor functions. Learning more about the regulation of TEMs by the tumor microenvironment may yield new strategies to ablate the tumor vasculature.
Similar articles
-
Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.Cancer Res. 2010 Jul 1;70(13):5270-80. doi: 10.1158/0008-5472.CAN-10-0012. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530679
-
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.Blood. 2007 Jun 15;109(12):5276-85. doi: 10.1182/blood-2006-10-053504. Epub 2007 Feb 27. Blood. 2007. PMID: 17327411
-
Expression of Tie-2 by human monocytes and their responses to angiopoietin-2.J Immunol. 2007 Jun 1;178(11):7405-11. doi: 10.4049/jimmunol.178.11.7405. J Immunol. 2007. PMID: 17513791
-
Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications.Trends Immunol. 2007 Dec;28(12):519-24. doi: 10.1016/j.it.2007.09.004. Epub 2007 Nov 5. Trends Immunol. 2007. PMID: 17981504 Review.
-
The paracrine role of Tie-2-expressing monocytes in tumor angiogenesis.Stem Cells Dev. 2009 Jun;18(5):703-6. doi: 10.1089/scd.2008.0385. Stem Cells Dev. 2009. PMID: 19186995 Review.
Cited by
-
Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis.Sci Rep. 2015 Mar 9;5:8888. doi: 10.1038/srep08888. Sci Rep. 2015. PMID: 25749075 Free PMC article.
-
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.Acta Neuropathol. 2012 Dec;124(6):763-75. doi: 10.1007/s00401-012-1066-5. Epub 2012 Nov 11. Acta Neuropathol. 2012. PMID: 23143192 Free PMC article. Review.
-
The Vascular Microenvironment in Glioblastoma: A Comprehensive Review.Biomedicines. 2022 May 31;10(6):1285. doi: 10.3390/biomedicines10061285. Biomedicines. 2022. PMID: 35740307 Free PMC article. Review.
-
The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.BMC Immunol. 2011 Jun 6;12:35. doi: 10.1186/1471-2172-12-35. BMC Immunol. 2011. PMID: 21645356 Free PMC article.
-
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.J Transl Med. 2009 Jun 19;7:49. doi: 10.1186/1479-5876-7-49. J Transl Med. 2009. PMID: 19545375 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous